Ultrasound-guided percutaneous radiofrequency ablation of renal tumors: early clinical experience

GUO Fang; LI Jia; CHEN Lei; HU Bing

doi:10.19732/j.cnki.1008-617X.2018.04.007

您当前的位置：

首页 >

文章列表页 >

Ultrasound-guided percutaneous radiofrequency ablation of renal tumors: early clinical experience

更新时间：2025-12-15

- Ultrasound-guided percutaneous radiofrequency ablation of renal tumors: early clinical experience
- Vol. 27, Issue 4, Pages: 279-284(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.19732/j.cnki.1008-617X.2018.04.007
  CLC：
- Published Online：17 September 2018，
  
  Published：17 September 2018
- 稿件说明：
移动端阅览
郭芳,李佳,陈磊,等. 超声引导下经皮肾脏肿瘤射频消融术的早期经验[J]. 肿瘤影像学, 2018, 27(4): 279-284 https://doi.

org/10.19732/j.cnki.1008-617X.2018.04.007
郭芳,李佳,陈磊,等. 超声引导下经皮肾脏肿瘤射频消融术的早期经验[J]. 肿瘤影像学, 2018, 27(4): 279-284 https://doi. DOI： 10.19732/j.cnki.1008-617X.2018.04.007.

org/10.19732/j.cnki.1008-617X.2018.04.007 DOI：

摘要

目的：

探讨超声引导下经皮射频消融（radiofrequency ablation，RFA)技术治疗肾脏肿瘤的有效性及安全性。

方法：

31例肾肿瘤患者接受RFA治疗，其中3例为姑息治疗，随访观察疗效及并发症。平均随访时间为24.6个月，随访方式以超声造影为主，增强CT或MRI为辅。

结果：

以肿瘤灭活为目标的28例肿瘤中，27例（96.4%）得到成功治疗，其中22例经1次RFA、4例经2次RFA、1例经3次RFA后达到完全消融。完全消融的27例肾肿瘤中，2例（7.4%）出现局部复发。肿瘤大小是影响RFA成功的重要因素（

=0.017），肿瘤直径3.5 cm可作为预测RFA成功的临界值（

=0.021），但肿瘤大小与是否出现局部复发并无明显关联（

=0.129）。此外，患者年龄、性别及肿瘤位置与肿瘤是否能完全消融或是否出现局部复发无明显相关。11例（35.5%）患者在RFA后出现自限性并发症，无严重并发症发生。

结论：

超声引导下经皮RFA能有效治疗直径3.5 cm的肾肿瘤，并发症发生率低，但长期疗效还需进一步观察。

Abstract

Objective:

To investigate the efficacy

safety of ultrasound-guided percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors.

Methods:

A total of 31 patients with single renal tumor were treated with RFA

of which 3 cases received the palliative care. The efficacy and complications of RFA were observed. The mean follow-up period was 24.6 months. Contrast-enhanced ultrasound (CEUS) was used to identify residues and recurrences after treatment

assisted by contrast-enhanced CT and M

RI.

Results:

Therapeutic success was achieved in 27 of 28 tumors (96.4%): 22 tumors were completely ablated after one therapy

4 tumors underwent two therapies

and 1 tumor underwent three therapies. 2 of 27 (7.4%) complete-ablated tumors had local recurrence. Tumor size was found to be an important factor affecting therapeutic success (

=0.017). The tumor diameter of 3.5 cm could be used as the threshold to predict RFA success (

=0.021)

but the tumor size was not related to local recurrence (

=0.129). Moreover

patients age

gender and tumor location had no correlation with either RFA success rate or local recurrence rate. 11 out of 27 (35.5%) patients developed self-limited complications

and no serious complications were observed.

Conclusion:

Ultrasound-guided percutaneous RFA is safe and effective in the treatment of renal tumors

especially in those with tumor diameter 3.5 cm. Nevertheless

further large comparative studies are needed to validate this approach.

关键词

Keywords

references

Views

1604

下载量

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Feasibility study on optical navigation assisted cryoablation of thyroid nodules

CT-guided radiofrequency ablation for 157 cases of lung cancer complicated with pneumothorax

Ultrasound-guided percutaneous non-contact combined contact radiofrequency ablation for the treatment of subcapsular small hepatocellular carcinoma

Ultrasound-guided treatment of predominantly cystic thyroid nodules: a comparative study between lauromacrogol injection therapy and radiofrequency ablation

Analysis of complications of laser ablation in pig lungs

Related Author

LUO Yukun

WANG Junchen

HAN Runzhe

ZHANG Mingbo

SUN Hao

YANG Rui

LIU Jiwei

HE Zheng

Related Institution

Department of Ultrasound, The First Medical Center of Chinese PLA General Hospital

School of general engineering, Beihang University

Department of Ultrasound, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

The First Department of Ultrasound, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

Department of Ultrasonography, the First Affiliated Hospital, Institute of Diagnostic and Interventional Ultrasound, Sun Yat-sen University

AI问答

⁰